Clinical Study of Cord Blood-derived IL-10/IL-15 CD19-CAR NK in the Treatment of Refractory/Relapsed B-cell NHL

NCT06707259 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

24

Enrollment

OTHER

Sponsor class

Conditions

B-cell Non Hodgkin Lymphoma

Interventions

BIOLOGICAL: anti-CD19 IL10/IL15 CAR-NK

Sponsor

Second Affiliated Hospital, School of Medicine, Zhejiang University